Japanese biotech firm Rakuten Medical wants to bring its novel ‘lightsaber’ cancer cure to the U.S.

In the short-term, the firm is looking to enter markets close to home—including Taiwan, Macau, Singapore, Hong Kong and Saudi Arabia.

From the publisher's summary